François Collin

2.3k total citations
28 papers, 868 citations indexed

About

François Collin is a scholar working on Plant Science, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, François Collin has authored 28 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Plant Science, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in François Collin's work include Multiple Sclerosis Research Studies (5 papers), Wheat and Barley Genetics and Pathology (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). François Collin is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Wheat and Barley Genetics and Pathology (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). François Collin collaborates with scholars based in United States, Poland and France. François Collin's co-authors include Mirosław Kwaśniewski, Adam Krętowski, Vincent Miller, Terence P. Speed, Julia Brettschneider, Benjamin M. Bolstad, Anna Szałkowska, Joanna Reszeć, Karolina Chwiałkowska and Agnieszka Bielska and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

François Collin

25 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Collin United States 13 357 218 150 116 94 28 868
Jill Kolesar United States 19 296 0.8× 146 0.7× 329 2.2× 139 1.2× 102 1.1× 68 948
Falk C. Thiel Germany 22 260 0.7× 125 0.6× 203 1.4× 143 1.2× 82 0.9× 68 1.4k
Stephen M. Schleicher United States 19 609 1.7× 171 0.8× 373 2.5× 230 2.0× 66 0.7× 62 1.3k
R.P. Symonds United Kingdom 15 210 0.6× 157 0.7× 207 1.4× 182 1.6× 32 0.3× 36 826
Arafat Tfayli Lebanon 21 364 1.0× 277 1.3× 522 3.5× 229 2.0× 72 0.8× 95 1.3k
Marcelo Eidi Nita Brazil 16 338 0.9× 124 0.6× 391 2.6× 150 1.3× 173 1.8× 47 988
María Buxó Spain 15 286 0.8× 248 1.1× 196 1.3× 185 1.6× 112 1.2× 75 872
Azita Tiznobaik Iran 7 238 0.7× 184 0.8× 294 2.0× 55 0.5× 61 0.6× 17 838
Ahmed A. Zeeneldin Egypt 16 121 0.3× 145 0.7× 266 1.8× 90 0.8× 73 0.8× 43 588
Enrique Barrios Uruguay 17 238 0.7× 123 0.6× 338 2.3× 113 1.0× 131 1.4× 43 852

Countries citing papers authored by François Collin

Since Specialization
Citations

This map shows the geographic impact of François Collin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Collin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Collin more than expected).

Fields of papers citing papers by François Collin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Collin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Collin. The network helps show where François Collin may publish in the future.

Co-authorship network of co-authors of François Collin

This figure shows the co-authorship network connecting the top 25 collaborators of François Collin. A scholar is included among the top collaborators of François Collin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Collin. François Collin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gudowska-Sawczuk, Monika, Agnieszka Kulczyńska‐Przybik, François Collin, et al.. (2022). Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies. Neurologia i Neurochirurgia Polska. 57(1). 121–130. 3 indexed citations
4.
Kapica-Topczewska, Katarzyna, François Collin, Joanna Tarasiuk, et al.. (2021). Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland. Journal of Clinical Medicine. 10(4). 868–868. 12 indexed citations
5.
Kapica-Topczewska, Katarzyna, François Collin, Joanna Tarasiuk, et al.. (2020). Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland. Neurologia i Neurochirurgia Polska. 54(2). 161–168. 18 indexed citations
6.
Kapica-Topczewska, Katarzyna, François Collin, Joanna Tarasiuk, et al.. (2020). John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis. European Neurology. 83(5). 487–492. 3 indexed citations
7.
Guler, Gulfem D., Yuhong Ning, Chin‐Jen Ku, et al.. (2020). Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA. Nature Communications. 11(1). 5270–5270. 119 indexed citations
8.
Kapica-Topczewska, Katarzyna, Joanna Tarasiuk, François Collin, et al.. (2019). The effectiveness of interferon beta versus glatiramer acetate and natalizumab versus fingolimod in a Polish real-world population. PLoS ONE. 14(10). e0223863–e0223863. 6 indexed citations
9.
10.
Collin, François, Yuhong Ning, Gulfem D. Guler, et al.. (2019). Abstract 1372: Detection of early stage pancreatic cancer using 5–hydroxymethylcytosine signatures in circulating cell free DNA. Cancer Research. 79(13_Supplement). 1372–1372. 1 indexed citations
11.
Collin, François, et al.. (2015). Identifying traits leading to tolerance of wheat to Septoria tritici blotch. Field Crops Research. 180. 176–185. 12 indexed citations
12.
Sinicropi, Dominick, Kunbin Qu, François Collin, et al.. (2012). Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue. PLoS ONE. 7(7). e40092–e40092. 59 indexed citations
13.
Brettschneider, Julia, et al.. (2008). Rejoinder. Technometrics. 50(3). 279–283. 5 indexed citations
14.
Jones, Lesley, Daniel R. Goldstein, Gareth Hughes, et al.. (2006). Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics. 7(1). 211–211. 31 indexed citations
15.
Ray, G. Thomas, François Collin, Tracy A. Lieu, et al.. (2000). The Cost of Health Conditions in a Health Maintenance Organization. Medical Care Research and Review. 57(1). 92–109. 74 indexed citations
16.
Miller, Vincent, et al.. (1999). Smoking-attributable medical care costs in the USA. Social Science & Medicine. 48(3). 375–391. 94 indexed citations
17.
Steib, A., et al.. (1998). Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?. Liver Transplantation and Surgery. 4(2). 152–157. 41 indexed citations
18.
Lizard‐Nacol, Sarab, Rosette Lidereau, François Collin, et al.. (1995). Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy.. PubMed. 55(19). 4416–9. 31 indexed citations
19.
Lizard‐Nacol, Sarab, et al.. (1994). [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].. PubMed. 81(9). 780–4. 1 indexed citations
20.
Collin, François. (1955). Control of barley grass in Hawkes Bay. Proceedings of the New Zealand Weed Control Conference. 8. 23–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jill Kolesar Breakdown of academic impact, for papers by Falk C. Thiel Breakdown of academic impact, for papers by Stephen M. Schleicher Breakdown of academic impact, for papers by R.P. Symonds Breakdown of academic impact, for papers by Arafat Tfayli Breakdown of academic impact, for papers by Marcelo Eidi Nita Breakdown of academic impact, for papers by María Buxó Breakdown of academic impact, for papers by Azita Tiznobaik Breakdown of academic impact, for papers by Ahmed A. Zeeneldin Breakdown of academic impact, for papers by Enrique Barrios
Rankless by CCL
2026